Lincomycin Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Lincomycin Hydrochloride Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Nov 6, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0009-0107-04
Dosage Form
Injection
Presentation
Lincocin, Injection, 10 mL multiple dose vial (NDC 0009-0107-04)
Initial Posting
Nov 6, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.